Splice variants of the cell surface glycoprotein CD44 associated with metastatic tumour cells are expressed in normal tissues of humans and cynomolgus monkeys
- 31 December 1995
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (13-14) , 2385-2391
- https://doi.org/10.1016/0959-8049(95)00420-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44Breast Cancer Research and Treatment, 1995
- Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteinsThe Lancet, 1994
- De-novo expression of CD44 and survival in gastric cancerThe Lancet, 1993
- Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44.The Journal of Experimental Medicine, 1993
- Splicing choice from ten variant exons establishes CD44 variabilityNucleic Acids Research, 1993
- Prevention of tumor metastasis formation by anti-variant CD44.The Journal of Experimental Medicine, 1993
- A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps.The Journal of cell biology, 1993
- A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cellsCell, 1991
- Retardation of metastatic tumor growth after immunization with metastasis‐specific monoclonal antibodiesInternational Journal of Cancer, 1990
- Production of monoclonal antibodies to human IFN-? and their use for analysis of the antigenic composition of various natural interferonsJournal of Cellular Physiology, 1982